{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T20:36:11Z","timestamp":1715718971779},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","interventional.theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.iccl.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T08:02:03Z","timestamp":1498809723000},"page":"487-493","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment"],"prefix":"10.1016","volume":"6","author":[{"given":"Emiliya","family":"Melkumova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iccl.2017.05.005_bib1","first-page":"e38","article-title":"Heart Disease and Stroke Statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.05.005_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.104.524371","article-title":"Patent foramen ovale and stroke","volume":"112","author":"Homma","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.05.005_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.iccl.2017.05.005_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2005.10.044","article-title":"Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study","volume":"47","author":"Meissner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2017.05.005_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1474-4422(11)70069-2","article-title":"Atypical presentations of acute cerebrovascular syndromes","volume":"10","author":"Edlow","year":"2011","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.iccl.2017.05.005_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.07.015","article-title":"Stroke chameleons","volume":"23","author":"Dupre","year":"2014","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"8","key":"10.1016\/j.iccl.2017.05.005_bib7","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.018","article-title":"Predictors of acute stroke mimics in 8187 patients referred to a stroke service","volume":"22","author":"Merino","year":"2013","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"21","key":"10.1016\/j.iccl.2017.05.005_bib8","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"Cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2017.05.005_bib9","series-title":"STROKE pathophysiology, diagnosis, and management","first-page":"707","article-title":"Cryptogenic stroke","author":"O'Donnell","year":"2016"},{"key":"10.1016\/j.iccl.2017.05.005_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.iccl.2017.05.005_bib11","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","article-title":"Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?","volume":"40","author":"Alsheikh-Ali","year":"2009","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.iccl.2017.05.005_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1747-4949.2012.00843.x","article-title":"The risk of paradoxical embolism (RoPE) study: initial description of the completed database","volume":"8","author":"Thaler","year":"2013","journal-title":"Int J Stroke"},{"issue":"7","key":"10.1016\/j.iccl.2017.05.005_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.iccl.2017.05.005_bib14","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2017.05.005_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2017.05.005_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/eb-2012-100736","article-title":"Closure of a patent foramen ovale with a device does not offer a greater benefit than medical therapy alone for the prevention of recurrent cerebrovascular events","volume":"18","author":"Mattle","year":"2013","journal-title":"Evid Based Med"},{"issue":"12","key":"10.1016\/j.iccl.2017.05.005_bib17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Caroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2017.05.005_bib18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.iccl.2017.05.005_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke : pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2017.05.005_bib20","unstructured":"FDA approves new device for prevention of recurrent strokes in certain patients. U.S. Food & Drug Administration Website. 2016. Available at: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm527096.htm. Accessed March 20, 2016."},{"key":"10.1016\/j.iccl.2017.05.005_bib21","unstructured":"Thaler D. RESPECT: Final Long-term Outcomes from a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke. Oral presentation at: Transcatheter Cardiovascular Therapeutics Annual Meeting. Washington, DC, November 1, 2016."},{"issue":"3","key":"10.1016\/j.iccl.2017.05.005_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.0000000000000589","article-title":"Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs","volume":"83","author":"Thaler","year":"2014","journal-title":"Neurology"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745817300718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745817300718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T19:52:15Z","timestamp":1569613935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745817300718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2211745817300718"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2017.05.005","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}